Application

18253903 · EXPRESSION TECHNOLOGY FOR ANTIBODY CONSTRUCTS

Filed 2023-05-22 · Pending The official file ↗ · Art unit 1632 · Examiner David A Montanari Typical · CPC C07K 16/468 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

28.9 mo

to disposition n/a

Statutes raised

103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.